The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adjuvant durvalumab or tislelizumab combined with S-1 for resected high-risk biliary tract cancers in China: A multicenter, two-cohort, single-arm, open-label, phase 2 trial preliminary analysis.
 
Dayong Cao
No Relationships to Disclose
 
Jing Zhang
No Relationships to Disclose
 
Wenjie Liu
No Relationships to Disclose
 
Airu Tian
No Relationships to Disclose
 
Hongguang Wang
No Relationships to Disclose
 
Yongkun Sun
No Relationships to Disclose